1[14]Domanski M,Mitchell G,Pfeifer M,et al.Pulse pressure and cardiovascular disease-related mortality:follow-up study of the multiple risk factor intervention trial (MRFIT).JAMA,2002,287:2677-2683.
2[15]Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction:interim report from the Chinese cardiac study (CCS-1).Lancet,1995,18,345:686-687.
4[17]Parving HH.Hypertension and diabetes:the scope of the problem.Blood Press Suppl,2001(Suppl 2):S25-S31.
5[18]Lewis EJ,Hunsicker LG,Clarke WR,et al.Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.N Engl J MED,2001,345:851-860.
6[19]Juliusa S,Majahalmea S,Palatinic P.Antihypertensive treatment of patients with diabetes and hypertension.American Journal of Hypertension,2001,14:S310-S316.
7[20]Emanueli C,Salis MB,Stacca T,et al.Ramipril improves hemodynamic recovery but not microvascular response to ischemia in spontaneously hypertensive rats.Am J Hypertens,2002,15:410-415.
8[21]Bonaa KH,Thelle DS.Association between blood pressure and serum lipids in a population the tromso study.Circulation,1991,83:1305-1314.
9[22]Rachmani R,Ravid M.Risk factors for nephropathy in type 2 diabetes mellitus.Compr Ther,1999,2:366-369.
10[23]Snow V,Weiss KB,Mottur-Pilson C.Clinical efficacy assessment subcommittee of the American college of physicians.The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus.Ann Intern Med,2003,138:587-592.
7Murata T,Takahashi T,Omori M,et al.Association of abnormaldiurnal blood pressure variation with the development of silent cerebral infarction in patients with late life onset depression.Generai Hospital Psychiatry,2003,25:298-300.
